Handling of allergen immunotherapy in the COVID‐19 pandemic: an ARIA‐EAACI statement
The current COVID-19 pandemic influences many areas of social life, medical treatments
and the way allergy diagnosis and treatment is performed. Allergen-specific immunotherapy …
and the way allergy diagnosis and treatment is performed. Allergen-specific immunotherapy …
COVID‐19 pandemic and allergen immunotherapy—an EAACI survey
Background As in many fields of medical care, the coronavirus disease 2019 (COVID‐19)
resulted in an increased uncertainty regarding the safety of allergen immunotherapy (AIT) …
resulted in an increased uncertainty regarding the safety of allergen immunotherapy (AIT) …
[HTML][HTML] Allergic respiratory disease care in the COVID-19 era: a EUFOREA statement
C Bachert, L Bjermer, Z Diamant, P Gevaert… - World Allergy …, 2020 - Elsevier
Spring and Summer 2020 are unique in that the challenges of care for those suffering from
pollen allergy coincide with the COVID-19 pandemic. Several considerations are important …
pollen allergy coincide with the COVID-19 pandemic. Several considerations are important …
Considerations on biologicals for patients with allergic disease in times of the COVID‐19 pandemic: an EAACI statement
The outbreak of the SARS‐CoV‐2‐induced coronavirus disease 2019 (COVID‐19)
pandemic re‐shaped doctor‐patient interaction and challenged capacities of healthcare …
pandemic re‐shaped doctor‐patient interaction and challenged capacities of healthcare …
COVID‐19 pandemic: practical considerations on the organization of an allergy clinic—an EAACI/ARIA Position Paper
O Pfaar, L Klimek, M Jutel, CA Akdis, J Bousquet… - Allergy, 2021 - Wiley Online Library
Background The coronavirus disease 2019 (COVID‐19) has evolved into a pandemic
infectious disease transmitted by the severe acute respiratory syndrome coronavirus (SARS …
infectious disease transmitted by the severe acute respiratory syndrome coronavirus (SARS …
[HTML][HTML] Use of biologicals in allergic and type-2 inflammatory diseases during the current COVID-19 pandemic: position paper of Ärzteverband Deutscher …
L Klimek, O Pfaar, M Worm, T Eiwegger… - Allergologie …, 2020 - ncbi.nlm.nih.gov
Background: Since the beginning of the COVID-19 pandemic, the treatment of patients with
allergic and atopy-associated diseases has faced major challenges. Recommendations for …
allergic and atopy-associated diseases has faced major challenges. Recommendations for …
A compendium answering 150 questions on COVID‐19 and SARS‐CoV‐2
Abstract In December 2019, China reported the first cases of the coronavirus disease 2019
(COVID‐19). This disease, caused by the severe acute respiratory syndrome–related …
(COVID‐19). This disease, caused by the severe acute respiratory syndrome–related …
One hundred and ten years of allergen immunotherapy: a journey from empiric observation to evidence
One hundred and ten years after Noon's first clinical report of the subcutaneous application
of allergen extracts, allergen immunotherapy (AIT) has evolved as the most important pillar …
of allergen extracts, allergen immunotherapy (AIT) has evolved as the most important pillar …
Change in allergy practice during the COVID-19 pandemic
AB Ozturk, A Baççıoğlu, O Soyer, E Civelek… - … Archives of Allergy and …, 2021 - karger.com
Background: International guidelines in asthma and allergy has been updated for COVID-19
pandemic and pandemic has caused dramatic changes in allergy and immunology services …
pandemic and pandemic has caused dramatic changes in allergy and immunology services …
ARIA‐EAACI statement on severe allergic reactions to COVID‐19 vaccines–an EAACI‐ARIA position paper
Further to the approval of the Coronavirus disease 2019 (COVID‐19) vaccine BNT162b2,
several severe anaphylaxis cases occured within the first few days of public vaccination. An …
several severe anaphylaxis cases occured within the first few days of public vaccination. An …